AD-2281

· Addpharma Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AD-2281, covering 2025-02-04 to 2025-10-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of AD-228A Compared to Coadministration of AD-2281 and AD-2282 [Phase 1]

See pricing